A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies peptic ulcer drugs market.

This report contains market size and forecasts of Peptic Ulcer Drugs in Germany, including the following market information:

Germany Peptic Ulcer Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)

Germany Peptic Ulcer Drugs Market Consumption, 2015-2020, 2021-2026, (M Unit)

Germany Peptic Ulcer Drugs Production Capacity, 2015-2020, 2021-2026, (M Unit)

Top Five Competitors in Germany Peptic Ulcer Drugs Market 2019 (%)

The global Peptic Ulcer Drugs market was valued at 16580 million in 2019 and is projected to reach US$ 19130 million by 2026, at a CAGR of 3.6% during the forecast period. While the Peptic Ulcer Drugs market size in Germany was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Peptic Ulcer Drugs production and consumption in Germany


Total Market by Segment:

Germany Peptic Ulcer Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Unit)

Germany Peptic Ulcer Drugs Market Segment Percentages, By Type, 2019 (%)

Proton Pump Inhibitors

Antacids

H2-Antagonists

Others

Proton pump inhibitors segment was estimated to account for a revenue share of 75.6% in 2019.

Germany Peptic Ulcer Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Unit)

Germany Peptic Ulcer Drugs Market Segment Percentages, By Application, 2019 (%)

Hospital and Clinic

Drugstore

Hospital and clinic segment was estimated to account for a sales share of 75.7% in 2019.


Competitor Analysis

The report also provides analysis of leading market participants including:

Total Peptic Ulcer Drugs Market Competitors Revenues in Germany, by Players 2015-2020 (Estimated), ($ millions)

Total Peptic Ulcer Drugs Market Competitors Revenues Share in Germany, by Players 2019 (%)

Total Germany Peptic Ulcer Drugs Market Competitors Sales, by Players 2015-2020 (Estimated), (M Unit)

Total Germany Peptic Ulcer Drugs Market Competitors Sales Market Share by Players 2019 ($ millions)


Further, the report presents profiles of competitors in the market, including the following:

Takeda Pharmaceutical

AstraZeneca

Pfizer

Teva Pharmaceuticals

EA Pharma

ASK Pharm

Luoxin Pharmaceutical

Abbott Laboratories

Yuhan Pharmaceutical